On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Ranked No. 1 Globally in Multi-Cancer Screening and Detection Test Volume

Company: AnPac Bio-Medical Science Co. Ltd. (ANPC)
Category: News

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that Frost & Sullivan Company, a leading and well-known U.S. market analysis and research firm, has ranked AnPac Bio globally as number one in worldwide multiple cancer screening and detection volume in a recent research report. Based on data accumulated through the end of 2020, the report included next generation cancer screening and detection technologies, including circulating tumor cells (“CTCs”), circulating-DNA (“CT-DNA”), exosome, cancer differentiation analysis (“CDA”), mRNA, and other emerging technologies. Specifically, for next generation cancer screening and detection, the report ranked AnPac Bio globally as number one in total volume of multi-cancer screening and detection, with 216,600 detection tests, while GRAIL Company was ranked globally number two with 135,100 detection tests. AnPac Bio was also ranked global number one in the category of volume of commercial multi-cancer tests (for next generation cancer screening and detection), with 172,900 detection tests. “We are very pleased with this significant global number one ranking, which signifies AnPac Bio as a global leader and the most accepted player in the field of multi-cancer screening and detection,” said Dr. Chris Yu, CEO and chairman of AnPac Bio. “The increasing volume in multi-cancer screening and detection indicates that our multi-cancer vision is clearly winning. We are even more excited by the progress in our multi-cancer screening platform and that more and more experts and customers are embracing this novel and great idea. We will work very hard to ensure that our multi-cancer screening and detection technology will continue to be adopted by the population and will save millions of lives.”

To view the full press release, visit https://nnw.fm/Bm9WU

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio a biotechnology company focused on early cancer screening and detection, with 150 issued patents as of Sept. 30, 2021. With two certified clinical laboratories in China and one “CLIA” and “CAP” accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer screening and detection tests, including “CDA” (Cancer Differentiation Analysis), bio-chemical, immunological and genomics tests. According to Frost & Sullivan, AnPac Bio is number one in total volume of multi-cancer screening and detection, with 216,600 detection tests. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of over 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://nnw.fm/ANPC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217